Commonwealth Biotechnologies News

Mimotopes Pty Ltd, a subsidiary of Commonwealth Biotechnologies Inc. , is pleased to announce that it has been awarded a major supply agreement for the synthesis of peptide libraries that will be used in screening dengue virus and Mycobacterium tuberculosis.

A complete list of all headlines and biomedical stock developments can be found on BioMedReports.Com On 11/09/09, CEL-SCI Corporation announced Dr.

Sep 3, 2009 - Commonwealth Biotechnologies, Inc. is pleased to announce that it has executed a definitive agreement to acquire all of the outstanding shares of GL Biochem Ltd, as well as all of the outstanding shares of GL Biochem Ltd, GL Peptide Ltd, and 86% of the shares of GL Peptide Ltd, three businesses affiliated with GL .

Commonwealth Biotechnologies, Inc. is struggling to prevent its delisting as it works toward completing an acquisition of peptide maker GL Biochem of Shanghai, a deal the company calls "transformative." In early June, CBI announced it would issue 6.6 million shares of its common stock to acquire GL Biochem.

Commonwealth Biotechnologies, Inc. is pleased to announce a market update regarding several recent and proposed major transactions that management believes, together, will redefine CBI's asset base, business model and financial performance.

Commonwealth Biotechnologies Inc sold intellectual property rights to an Australian-based company, Biosignal, and got a $2.6 million payday in return.

They had a vision to - RICHMOND, Va.-- --Commonwealth Biotechnologies, Inc. , a life sciences contract research organization and biotechnology company , today announced that as of July 22, - DUBLIN-- --Research and Markets has announced the addition of the "The Global Ship Building & Repair Industry Report" report to - COLUMBIA, Md.-- --Tecore ...

Commonwealth Biotechnologies, Inc. is pleased to announce that an agreement has been signed with Bostwick Laboratories, Inc.

AUSTIN, Texas-- --Stratus Properties Inc. announced today that on July 8, 2009, Stratus received a letter from The NASDAQ Stock Market, Inc.

Commonwealth Biotechnologies, Inc. is pleased to announce that it has reached an agreement with its PIPE investors to extend for 6 months its convertible note facilities of approximately $1.4M that matured on June 30 and has also received consent to suspend the financial covenants under such note facilities through the 3rd Quarter.

Venturepharm Laboratories Ltd is pleased to inform that its NASDAQ flagship company, Commonwealth Biotechnologies, Inc.

The world of China life science last week issued news across a broad front of themes: long-term strategy, consolidation, new JVs, the latest vaccines, more capital, official accreditations and more.

Jun 11, 2009 - Commonwealth Biotechnologies, Inc. is pleased to provide the following market update reporting on its recently executed term sheet to acquire all of the outstanding shares of GL Biochem Ltd .

Jun 8, 2009 - Commonwealth Biotechnologies, Inc. is pleased to announce that it has executed an agreement to acquire all of the outstanding shares of GL Biochem Ltd , a privately owned Shanghai-based chemical company and the largest supplier of research-grade peptide products and peptide reagents globally.